Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2005.00255.x/fullpdf
Reference22 articles.
1. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
2. Indinavir Concentrations and Antiviral Effect
3. Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy Volunteers
4. The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria;Toxicology Research;2021-02-15
2. Harnessing Artificial Intelligence to Optimize Long‐Term Maintenance Dosing for Antiretroviral‐Naive Adults with HIV‐1 Infection;Advanced Therapeutics;2019-11-11
3. Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review;HIV Medicine;2019-04-22
4. Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling;Journal of Antimicrobial Chemotherapy;2017-09-26
5. Comparison of the Effectiveness of Low-Dose Indinavir/Ritonavir (IDV/r)- versus Atazanavir/Ritonavir (ATV/r)-Based Generic Antiretroviral Therapy in NNRTI-Experienced HIV-1-Infected Patients in India;Journal of the International Association of Physicians in AIDS Care;2011-02-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3